These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 23284010)
1. Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening. Machens A; Lorenz K; Dralle H J Clin Endocrinol Metab; 2013 Feb; 98(2):E336-45. PubMed ID: 23284010 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Effectiveness of Screening for Multiple Endocrine Neoplasia Type 2A. Machens A; Dralle H J Clin Endocrinol Metab; 2015 Jul; 100(7):2539-45. PubMed ID: 25946031 [TBL] [Abstract][Full Text] [Related]
3. Surgical management of MEN-1 and -2: state of the art. Akerström G; Stålberg P Surg Clin North Am; 2009 Oct; 89(5):1047-68. PubMed ID: 19836484 [TBL] [Abstract][Full Text] [Related]
4. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation. Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325 [TBL] [Abstract][Full Text] [Related]
5. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A. Asari R; Scheuba C; Kaczirek K; Niederle B Arch Surg; 2006 Dec; 141(12):1199-205; discussion 1205. PubMed ID: 17178962 [TBL] [Abstract][Full Text] [Related]
6. [The clinical characteristics and therapy of multiple endocrine neoplasia type 2]. Xie Y; Li HZ; Rong S; Zhu Y Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1096-9. PubMed ID: 15498294 [TBL] [Abstract][Full Text] [Related]
8. Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2. Machens A; Brauckhoff M; Holzhausen HJ; Thanh PN; Lehnert H; Dralle H J Clin Endocrinol Metab; 2005 Jul; 90(7):3999-4003. PubMed ID: 15827097 [TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia type 2. Wohllk N; Schweizer H; Erlic Z; Schmid KW; Walz MK; Raue F; Neumann HP Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):371-87. PubMed ID: 20833330 [TBL] [Abstract][Full Text] [Related]
10. Bilateral Pheochromocytomas in MEN2A Syndrome: A Two-Institution Experience. Lang BH; Yu HW; Lo CY; Lee KE; Garcia-Barcelo MM; Woo YC; Lee PC; Wong KP; Tam PK; Lam KS World J Surg; 2015 Oct; 39(10):2484-91. PubMed ID: 26071011 [TBL] [Abstract][Full Text] [Related]
11. Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons. Kraimps JL; Denizot A; Carnaille B; Henry JF; Proye C; Bacourt F; Sarfati E; Dupond JL; Maes B; Travagli JP; Boneu A; Roger P; Houdent C; Barbier J; Modigliani E World J Surg; 1996 Sep; 20(7):808-12; discussion 812-3. PubMed ID: 8678955 [TBL] [Abstract][Full Text] [Related]
12. Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma. Elston MS; Meyer-Rochow GY; Holdaway I; Conaglen JV Horm Metab Res; 2012 May; 44(5):339-42. PubMed ID: 22274720 [TBL] [Abstract][Full Text] [Related]
14. Surgical management of hereditary pheochromocytoma. Yip L; Lee JE; Shapiro SE; Waguespack SG; Sherman SI; Hoff AO; Gagel RF; Arens JF; Evans DB J Am Coll Surg; 2004 Apr; 198(4):525-34; discussion 534-5. PubMed ID: 15051000 [TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia type 2. Lodish M Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Castinetti F; Qi XP; Walz MK; Maia AL; Sansó G; Peczkowska M; Hasse-Lazar K; Links TP; Dvorakova S; Toledo RA; Mian C; Bugalho MJ; Wohllk N; Kollyukh O; Canu L; Loli P; Bergmann SR; Biarnes Costa J; Makay O; Patocs A; Pfeifer M; Shah NS; Cuny T; Brauckhoff M; Bausch B; von Dobschuetz E; Letizia C; Barczynski M; Alevizaki MK; Czetwertynska M; Ugurlu MU; Valk G; Plukker JT; Sartorato P; Siqueira DR; Barontini M; Szperl M; Jarzab B; Verbeek HH; Zelinka T; Vlcek P; Toledo SP; Coutinho FL; Mannelli M; Recasens M; Demarquet L; Petramala L; Yaremchuk S; Zabolotnyi D; Schiavi F; Opocher G; Racz K; Januszewicz A; Weryha G; Henry JF; Brue T; Conte-Devolx B; Eng C; Neumann HP Lancet Oncol; 2014 May; 15(6):648-55. PubMed ID: 24745698 [TBL] [Abstract][Full Text] [Related]
17. Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: report of a case and a review of the Japanese literature. Oishi S; Sasaki M; Sato T; Isogai M Jpn J Clin Oncol; 1995 Aug; 25(4):153-8. PubMed ID: 7666591 [TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Yip L; Cote GJ; Shapiro SE; Ayers GD; Herzog CE; Sellin RV; Sherman SI; Gagel RF; Lee JE; Evans DB Arch Surg; 2003 Apr; 138(4):409-16; discussion 416. PubMed ID: 12686527 [TBL] [Abstract][Full Text] [Related]
19. Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy. Scholten A; Valk GD; Ulfman D; Borel Rinkes IH; Vriens MR Ann Surg; 2011 Dec; 254(6):1022-7. PubMed ID: 22107743 [TBL] [Abstract][Full Text] [Related]
20. Laparoscopic resection of periadrenal paraganglioma in a patient with multiple endocrine neoplasia type 2A. Nomura T; Takahashi M; Ando T; Sato F; Fujii S; Mimata H Surg Laparosc Endosc Percutan Tech; 2011 Feb; 21(1):e31-3. PubMed ID: 21304370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]